Clinical Trial Update: Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Enbrel (etanercept) for sub-acute pulmonary dysfunction after allogeneic stem cell transplantation has completed, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans
• Lung Injury
• Respiratory Distress Syndrome

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Lung Injury, Acute, Respiratory Distress Syndrome, Adult | Phase 2 | Status: COMPLETED | Results posted: 2014-06-19